Cresco Spine earned FDA 510(k) clearance for its spring distraction system, the company said in a Jan. 19 LinkedIn post.
The SDS implant is designed for addressing early onset scoliosis, and it previously earned the FDA’s Breakthrough Device Designation.
Cresco Spine plans a controlled release of SDS in the U.S. and Canada.
